Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection
Masashi Takenaka, Vijay Subramanian, Venkataswarup Tiriveedhi, Donna Phelan, Ramsey Hachem, Elbert Trulock, Andrew E. Gelman, G. Alexander Patterson, Kiyotaka Hoshinaga, Thalachallour Mohanakumar
Dive into the research topics of 'Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection'. Together they form a unique fingerprint.